Drug Eluting Balloons (DEB)

Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Product Code GDA01047
Publication Date December 2011
Publisher GlobalData
Product Type Report
Pages 91
ISBN Number not applicable
Change currency
PDF £2,215.00 €2,667 $3,502 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Drug Eluting Balloons (DEB)

Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData's new report, 'Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017' provides key data, information and analysis on the global drug eluting balloons market. The report provides market landscape, competitive landscape and market trends information on the drug eluting balloons market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market's dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Key geographies covered include Germany, France, Italy, the UK, Spain, China, Australia and India.
  • Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
  • Qualitative analysis of key market trends, market drivers, and restraints within the drug eluting balloons market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • Key players covered include B Braun, Eurocor and Invatec.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the drug eluting balloons globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
  • What's the next big thing in the drug eluting balloons market landscape? - Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global drug eluting balloons market and the factors shaping it.

Contents

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 GlobalData Report Guidance
  • 3 Major Cardiovascular Indications Approved for Drug Eluting Balloons
    • 3.1 In-Stent Restenosis
      • 3.1.1 Introduction
      • 3.1.2 Pathophysiology
      • 3.1.3 Etiology - Risk Factors
    • 3.2 In-Stent Restenosis Epidemiology - Global
      • 3.2.1 Treatment Flow Model
    • 3.3 Peripheral Vascular Disease - Overview and Pathophysiology
      • 3.3.1 Introduction
    • 3.4 Peripheral Vascular Disease Epidemiology - Global
      • 3.4.1 Treatment Flow Model
    • 3.5 Peripheral Vascular Disease: Device Based Treatment Modalities and their Outcomes
  • 4 Drug Eluting Balloons - Global Market Characterization
    • 4.1 Global Drug Eluting Balloons Market, Revenue ($m), 2003-2010
    • 4.2 Global Drug Eluting Balloons Market, Revenue ($m), 2010-2017
    • 4.3 Global Drug Eluting Balloons Market, Volume (Units), 2007-2010
    • 4.4 Global Drug Eluting Balloons Market, Volume (Units), 2010-2017
    • 4.5 Global Drug Eluting Balloons, Market Dynamics
      • 4.5.1 Market Drivers
      • 4.5.2 Market Restraints
    • 4.6 Drug Eluting Balloons - Unmet Need and Opportunities
      • 4.6.1 Unmet Need
      • 4.6.2 Opportunities
  • 5 Drug Eluting Balloons Market, by Country, Revenue ($m), Volume, 2003-2017
    • 5.1 Germany Drug Eluting Balloons Market, Revenue ($m), 2003-2010
    • 5.2 Germany Drug Eluting Balloons Market, Revenue ($m), 2010-2017
    • 5.3 Germany Drug Eluting Balloons Market, Volume, 2003-2010
    • 5.4 Germany Drug Eluting Balloons Market, Volume, 2010-2017
    • 5.5 France Drug Eluting Balloons Market, Revenue ($m), 2003-2010
    • 5.6 France Drug Eluting Balloons Market, Revenue ($m), 2010-2017
    • 5.7 France Drug Eluting Balloons Market, Volume, 2003-2010
    • 5.8 France Drug Eluting Balloons Market, Volume, 2010-2017
    • 5.9 Spain Drug Eluting Balloons Market, Revenue ($m), 2003-2010
    • 5.10 Spain Drug Eluting Balloons Market, Revenue ($m), 2010-2017
    • 5.11 Spain Drug Eluting Balloons Market, Volume, 2003-2010
    • 5.12 Spain Drug Eluting Balloons Market, Volume, 2010-2017
    • 5.13 Italy Drug Eluting Balloons Market, Revenue ($m), 2003-2010
    • 5.14 Italy Drug Eluting Balloons Market, Revenue ($m), 2010-2017
    • 5.15 Italy Drug Eluting Balloons Market, Volume, 2003-2010
    • 5.16 Italy Drug Eluting Balloons Market,Volume, 2010-2017
    • 5.17 The UK Drug Eluting Balloons Market, Revenue ($m), 2003-2010
    • 5.18 The UK Drug Eluting Balloons Market, Revenue ($m), 2010-2017
    • 5.19 The UK Drug Eluting Balloons Market, Volume, 2003-2010
    • 5.20 The UK Drug Eluting Balloons Market, Volume, 2010-2017
    • 5.21 Australia Drug Eluting Balloons Market, Revenue ($m), 2003-2010
    • 5.22 Australia Drug Eluting Balloons Market, Revenue ($m), 2010-2017
    • 5.23 Australia Drug Eluting Balloons Market, Volume, 2003-2010
    • 5.24 Australia Drug Eluting Balloons Market,Volume, 2010-2017
    • 5.25 China Drug Eluting Balloons Market, Revenue ($m), 2003-2010
    • 5.26 China Drug Eluting Balloons Market, Revenue ($m), 2010-2017
    • 5.27 China Drug Eluting Balloons Market, Volume, 2003-2010
    • 5.28 China Drug Eluting Balloons Market,Volume, 2010-2017
    • 5.29 India Drug Eluting Balloons Market, Revenue ($m), 2003-2010
    • 5.30 India Drug Eluting Balloons Market, Revenue ($m), 2010-2017
    • 5.31 India Drug Eluting Balloons Market, Volume, 2003-2010
    • 5.32 India Drug Eluting Balloons Market,Volume, 2010-2017
  • 6 Global Drug Eluting Balloons Market - Company Share Analysis and Key Market Participants
    • 6.1 Global Drug Eluting Balloons Market, Company Share (%), 2010
    • 6.2 B. Braun
      • 6.2.1 Overview
      • 6.2.2 Drug Eluting Balloons Portfolio
    • 6.3 Eurocor
      • 6.3.1 Overview
    • 6.4 Invatec
      • 6.4.1 Overview
      • 6.4.2 Drug Eluting Balloons Portfolio
    • 6.5 Aachen Resonance GmbH
      • 6.5.1 Overview
      • 6.5.2 Drug Eluting Balloons Portfolio
  • 7 Global PTCA Coronary Drug Eluting Balloons - Key Marketed Products
    • 7.1 SeQuent Please
      • 7.1.1 Product Overview and Description
      • 7.1.2 Key Technology
      • 7.1.3 Past Clinical Studies
      • 7.1.4 Ongoing Clinical Trials
    • 7.2 DIOR Paclitaxel-Eluting Coronary Balloon Catheter
      • 7.2.1 Product Overview and Description
      • 7.2.2 Key Technology
      • 7.2.3 Past Clinical Studies
      • 7.2.4 Ongoing Clinical Trials
    • 7.3 Elutax
      • 7.3.1 Product Overview and Description
      • 7.3.2 Key Technology
      • 7.3.3 Past Clinical Studies
    • 7.4 Moxy Drug Coated Balloon Catheter
      • 7.4.2 Past Clinical Studies
      • 7.4.3 Ongoing Clinical Trials
  • 8 Global PTA Drug Eluting Balloons Market - Key Marketed Products
    • 8.1 Cotavance
      • 8.1.1 Product Description
      • 8.1.2 Key Technology
      • 8.1.3 Past Clinical Studies
      • 8.1.4 Ongoing Clinical Trials
    • 8.2 IN.PACT Paclitaxel Eluting Balloon Catheter Series
      • 8.2.1 Product Description
      • 8.2.2 Key Technology
      • 8.2.3 Past Clinical Studies
      • 8.2.4 Ongoing Clinical Trials
    • 8.3 FREEWAY 014
      • 8.3.1 Product Description
      • 8.3.2 Key Technology
      • 8.3.3 Past Clinical Studies
      • 8.3.4 Ongoing Clinical Study Results
  • 9 Global Drug Eluting Balloons Market - Strategic Pipeline Assessment
    • 9.1 Pipeline Technology Assessment
      • 9.1.1 Pipeline Technology Assessment for Drug Eluting Balloons by Development Stage for PTCA
      • 9.1.2 Pipeline Technology Assessment for Drug Eluting Balloons by Unmet Need
      • 9.1.3 Novel Pipeline Technology Assessment for Drug Eluting Balloons
    • 9.2 Profiles of Promising Products under Clinical Development
      • 9.2.1 Advance 18PTX
      • 9.2.2 Genesis DESA Catheter
      • 9.2.3 Drug-Eluting PTA Balloon Catheter
      • 9.2.4 Drug-Eluting Balloon
      • 9.2.5 PTCA Balloon Genistein-Coated Balloon Catheter
  • 10 Global Drug Eluting Balloons Market - Strategic Deals Analysis
    • 10.1 Key Acquisitions
      • 10.1.1 Medtronic Acquired Invatec
      • 10.1.2 MEDRAD Completes Acquisition of Possis Medical
      • 10.1.3 Opto Circuits Acquired Eurocor
    • 10.2 Key Partnerships
      • 10.2.1 Cardiovascular Systems Enters into an Agreement with Invatec
      • 10.2.2 Maxcor Enters into a Strategic Agreement with Micell Technologies
      • 10.2.3 Eurocor Enters into a Distribution Agreement with Goodman
      • 10.2.4 MEDRAD Enters into Licensing Agreement with B. Braun Melsungen
      • 10.2.5 DSM Biomedical and Caliber Therapeutics Form Partnership
      • 10.2.6 Aachen Resonance Enters into a Distribution Agreement with Biotronik
  • 11 Appendix
    • 11.1 Definitions
      • 11.1.1 PTCA Coronary Drug Eluting Balloons (DEB)
      • 11.1.2 PTA Peripheral Drug Eluting Balloons (DEB)
    • 11.2 Acronyms
    • 11.3 Sources
    • 11.4 Research Methodology
      • 11.4.1 Secondary Research
      • 11.4.2 Primary Research
      • 11.4.3 Models
    • 11.5 Expert Panel
    • 11.6 GlobalData Consulting
    • 11.7 Contact Us
    • 11.8 Disclaimer
    • 1.1 List of Tables
    • Table 1: Drug Eluting Balloons Market, Global, Revenue ($m), 2003-2010
    • Table 2: Drug Eluting Balloons Market, Global, Revenue ($m), 2010-2017
    • Table 3: Drug Eluting Balloons Market, Global, Volume (Units), 2007-2010
    • Table 4: Drug Eluting Balloons Market, Global, Volume (Units), 2010-2017
    • Table 5: Drug Eluting Balloons Clinical Studies Showing Favorable Results
    • Table 6: Population Aged 65 and Over, Percentage (%), Global, 2010-2030
    • Table 7: Drug Eluting Balloons Clinical Studies Showing Favorable Results
    • Table 8: Drug Eluting Balloons Market, Germany, Revenue ($m), 2003-2010
    • Table 9: Drug Eluting Balloons Market, Germany, Revenue ($m), 2010-2017
    • Table 10: Drug Eluting Balloons Market, Germany, Volume (Absolute), 2003-2010
    • Table 11: Drug Eluting Balloons Market, Germany, Volume (Absolute), 2010-2017
    • Table 12: Drug Eluting Balloons Market, France, Revenue ($m), 2003-2010
    • Table 13: Drug Eluting Balloons Market, France, Revenue ($m), 2010-2017
    • Table 14: Drug Eluting Balloons Market, France, Volume (Absolute), 2003-2010
    • Table 15: Drug Eluting Balloons Market, France, Volume (Absolute), 2010-2017
    • Table 16: Drug Eluting Balloons Market, Spain, Revenue ($m), 2003-2010
    • Table 17: Drug Eluting Balloons Market, Spain, Revenue ($m), 2010-2017
    • Table 18: Drug Eluting Balloons Market, Spain, Volume (Absolute), 2003-2010
    • Table 19: Drug Eluting Balloons Market, Spain, Volume (Absolute), 2010-2017
    • Table 20: Drug Eluting Balloons Market, Italy, Revenue ($m), 2003-2010
    • Table 21: Drug Eluting Balloons Market, Italy, Revenue ($m), 2010-2017
    • Table 22: Drug Eluting Balloons Market, Italy, Volume (Absolute), 2003-2010
    • Table 23: Drug Eluting Balloons Market, Italy, Volume (Absolute), 2010-2017
    • Table 24: Drug Eluting Balloons Market, The UK, Revenue ($m), 2003-2010
    • Table 25: Drug Eluting Balloons Market, The UK, Revenue ($m), 2010-2017
    • Table 26: Drug Eluting Balloons Market, The UK, Volume (Absolute), 2003-2010
    • Table 27: Drug Eluting Balloons Market, The UK, Volume (Absolute), 2010-2017
    • Table 28: Drug Eluting Balloons Market, Australia, Revenue ($m), 2003-2010
    • Table 29: Drug Eluting Balloons Market, Australia, Revenue ($m), 2010-2017
    • Table 30: Drug Eluting Balloons Market, Australia, Volume (Absolute), 2003-2010
    • Table 31: Drug Eluting Balloons Market, Australia, Volume (Absolute), 2010-2017
    • Table 32: Drug Eluting Balloons Market, China, Revenue ($m), 2003-2010
    • Table 33: Drug Eluting Balloons Market, China, Revenue ($m), 2010-2017
    • Table 34: Drug Eluting Balloons Market, China, Volume (Absolute), 2003-2010
    • Table 35: Drug Eluting Balloons Market, China, Volume (Absolute), 2010-2017
    • Table 36: Drug Eluting Balloons Market, India, Revenue ($m), 2003-2010
    • Table 37: Drug Eluting Balloons Market, India, Revenue ($m), 2010-2017
    • Table 38: Drug Eluting Balloons Market, India, Volume (Absolute), 2003-2010
    • Table 39: Drug Eluting Balloons Market, India, Volume (Absolute), 2010-2017
    • Table 40: Drug Eluting Balloons Market, Global, Key Company Shares (%), 2010
    • Table 41: B. Braun, Drug Eluting Balloons, Pipeline Products
    • Table 42: Eurocor, Drug Eluting Balloons, Pipeline Products
    • Table 43: Invatec, Drug Eluting Balloons, Pipeline Products
    • Table 44: Aachen Resonance, Drug Eluting Balloons, Pipeline Products
    • Table 45: List of Ongoing Clinical Trials, Sequent Please, 2011
    • Table 46: List of Ongoing Clinical Trials, DIOR, 2011
    • Table 47: List of Ongoing Clinical Trials, Moxy Drug Coated Balloon Catheter, 2011
    • Table 48: List of Ongoing Clinical Trials, Cotavance, 2011
    • Table 49: List of Ongoing Clinical Trials, IN.PACT Series
    • Table 50: List of Ongoing Clinical Trials, FREEWAY
    • Table 51: Advance 18 PTX Balloon Catheter - Advance 18PTX Balloon Catheter Study: Treatment of Lesions in Superficial Femoral Artery/Popliteal Artery with a Paclitaxel-Coated Balloon
    • 1.2 List of Figures
    • Figure 1: Treatment Flow Model, Drug Eluting Balloons for Treatment of In-Stent Restenosis, Global, 2010
    • Figure 2: Device Based Treatment Modalities for In-Stent Restenosis
    • Figure 3: Treatment Flow Model, Drug Eluting Balloons for Treatment of Peripheral Artery Disease, Global, 2010
    • Figure 4: Device Based Treatment Modalities for Peripheral Vascular Disease
    • Figure 5: Drug Eluting Balloons Market, Global, Revenue ($m), 2003-2010
    • Figure 6: Drug Eluting Balloons Market, Global, Revenue ($m), 2010-2017
    • Figure 7: Drug Eluting Balloons Market, Global, Volume (Units), 2007-2010
    • Figure 8: Drug Eluting Balloons Market, Global, Volume (Units), 2010-2017
    • Figure 9: Population Aged 65 and Over, Percentage (%), Global, 2010-2030
    • Figure 10: Unmet Need and Opportunities Analysis for Drug Eluting Balloons
    • Figure 11: Drug Eluting Balloons Market, Germany, Revenue ($m), 2003-2010
    • Figure 12: Drug Eluting Balloons Market, Germany, Revenue ($m), 2010-2017
    • Figure 13: Drug Eluting Balloons Market, Germany, Volume (Absolute), 2003-2010
    • Figure 14: Drug Eluting Balloons Market, Germany, Volume (Absolute), 2010-2017
    • Figure 15: Drug Eluting Balloons Market, France, Revenue ($m), 2003-2010
    • Figure 16: Drug Eluting Balloons Market, France, Revenue ($m), 2010-2017
    • Figure 17: Drug Eluting Balloons Market, France, Volume (Absolute), 2003-2010
    • Figure 18: Drug Eluting Balloons Market, France, Volume (Absolute), 2010-2017
    • Figure 19: Drug Eluting Balloons Market, Spain, Revenue ($m), 2003-2010
    • Figure 20: Drug Eluting Balloons Market, Spain, Revenue ($m), 2010-2017
    • Figure 21: Drug Eluting Balloons Market, Spain, Volume (Absolute), 2003-2010
    • Figure 22: Drug Eluting Balloons Market, Spain, Volume (Absolute), 2010-2017
    • Figure 23: Drug Eluting Balloons Market, Italy, Revenue ($m), 2003-2010
    • Figure 24: Drug Eluting Balloons Market, Italy, Revenue ($m), 2010-2017
    • Figure 25: Drug Eluting Balloons Market, Italy, Volume (Absolute), 2003-2010
    • Figure 26: Drug Eluting Balloons Market, Italy, Volume (Absolute), 2010-2017
    • Figure 27: Drug Eluting Balloons Market, The UK, Revenue ($m), 2003-2010
    • Figure 28: Drug Eluting Balloons Market, The UK , Revenue ($m), 2010-2017
    • Figure 29: Drug Eluting Balloons Market, The UK, Volume (Absolute), 2003-2010
    • Figure 30: Drug Eluting Balloons Market, The UK, Volume (Absolute), 2010-2017
    • Figure 31: Drug Eluting Balloons Market, Australia, Revenue ($m), 2003-2010
    • Figure 32: Drug Eluting Balloons Market, Australia, Revenue ($m), 2010-2017
    • Figure 33: Drug Eluting Balloons Market, Australia, Volume (Absolute), 2003-2010
    • Figure 34: Drug Eluting Balloons Market, Australia, Volume (Absolute), 2010-2017
    • Figure 35: Drug Eluting Balloons Market, China, Revenue ($m), 2003-2010
    • Figure 36: Drug Eluting Balloons Market, China, Revenue ($m), 2010-2017
    • Figure 37: Drug Eluting Balloons Market, China, Volume (Absolute), 2003-2010
    • Figure 38: Drug Eluting Balloons Market, China, Volume (Absolute), 2010-2017
    • Figure 39: Drug Eluting Balloons Market, India, Revenue ($m), 2003-2010
    • Figure 40: Drug Eluting Balloons Market, India, Revenue ($m), 2010-2017
    • Figure 41: Drug Eluting Balloons Market, India, Volume (Absolute), 2003-2010
    • Figure 42: Drug Eluting Balloons Market, India, Volume (Absolute), 2010-2017
    • Figure 43: Drug Eluting Balloons Market, Global, Company Share (%), 2010
    • Figure 44: Pipeline Technology Assessment for PTCA Coronary Drug Eluting Balloons by Development Stage, Europe, 2011
    • Figure 45: Pipeline Technology Assessment for PTA Drug Eluting Balloons by Development Stage, Europe, 2011
    • Figure 46: Pipeline Technology Assessment for Drug Eluting Balloons by Unmet Need